Proper Initiation of Warfarin Therapy
For outpatients who are sufficiently healthy, warfarin therapy should be initiated with 10 mg daily for the first 2 days followed by dosing based on INR measurements. 1
Initial Dosing Strategy
Outpatient Initiation
- Start with 10 mg daily for the first 2 days for healthy outpatients 1
- For elderly, debilitated patients, or those at increased risk of bleeding, use a lower initial dose of 5 mg daily 1, 2
- For very elderly patients, consider an even lower initial dose of 2-4 mg 3
Inpatient Initiation
- For hospitalized patients, especially those with acute thromboembolism requiring immediate anticoagulation:
Concurrent Parenteral Anticoagulation
- Overlap warfarin with parenteral anticoagulation (heparin, LMWH, or fondaparinux) for at least 5 days 1
- Continue parenteral anticoagulation until the INR has been in the therapeutic range (2.0-3.0) for at least 2 consecutive days 1
- When drawing blood for INR determination in patients receiving both heparin and warfarin, timing is critical:
- At least 5 hours after IV bolus heparin
- At least 4 hours after cessation of continuous IV heparin infusion
- At least 24 hours after subcutaneous heparin injection 2
Monitoring Protocol
Initial Monitoring Phase
- Check INR daily after administration of initial dose until INR stabilizes in therapeutic range 2
- Once therapeutic range is achieved for 2 consecutive days, reduce monitoring frequency 1
- Monitor 2-3 times weekly for 1-2 weeks, then less often according to stability of results 1, 3
Maintenance Monitoring
- When INR is stable, gradually extend monitoring intervals:
Target INR Ranges
- For most indications (venous thromboembolism, atrial fibrillation): INR 2.0-3.0 1, 5
- For mechanical heart valves:
- Bileaflet valves in aortic position: INR 2.0-3.0
- Tilting disk and bileaflet valves in mitral position: INR 2.5-3.5
- Caged ball or caged disk valves: INR 2.5-3.5 plus aspirin 75-100 mg/day 2
Dose Adjustments
- Adjust dose based on INR measurements, not by a fixed amount
- Most changes should alter the total weekly dose by 5-20% 3
- Single INR values slightly out of range may not require dose adjustment 3
- For INR >3.5, hold next dose and resume at lower dose (3-4 mg) when INR <3.5 4
- For INR <2.0, increase dose by 10-20% 4
Common Pitfalls and Caveats
Loading dose caution: Using a large loading dose increases hemorrhagic complications without providing more rapid protection against thrombi formation 2
Medication interactions: Many medications interact with warfarin, requiring more frequent INR monitoring when starting or stopping other medications 2
Diet considerations: Fluctuations in vitamin K intake can affect warfarin response; patients should maintain consistent dietary habits
Monitoring timing: For patients receiving both heparin and warfarin, timing of INR testing is critical to avoid interference 2
Elderly patients: Older patients typically require lower maintenance doses and are at higher risk of bleeding complications 1, 5
Genetic variations: Patients with certain genetic variations in CYP2C9 and VKORC1 enzymes may require lower doses 2, 6
Missed doses: Patients should not double the next dose to make up for missed doses 2
By following this structured approach to warfarin initiation and monitoring, clinicians can optimize anticoagulation efficacy while minimizing bleeding risks.